RBP4 Aggravates Diabetic Retinopathy by Inducing Microglial Activation and Endothelial Inflammation
Diabetes · 01.08.2026 · 75 (8) · 1460-1476
DOI: 10.2337/db25-0816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 28.05.2026. Verfasst von Ying Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Inflammation Biology, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Departmen…. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Microglia, Retinol-Binding Proteins, Plasma, Inflammation. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is recognized as an inflammatory neurovascular complication, with neuronal deficits preceding vascular symptoms. This study identified elevated serum retinol-binding protein 4 (RBP4) as a risk factor for DR, because it induces retinal neuronal injuries and exacerbates vascular defects. Vitreous RBP4 levels were significantly elevated in patients with DR compared with those with macular disease. Elevated vitreous and serum RBP4 levels exacerbated hyperglycemia-induced endothelial inflammation, retinal vascular leakage, pericyte loss, and acellular capillaries in streptozotocin-induced diabetic mice. Progressive retinal degeneration and impaired electroretinography function were exhibited with RBP4 overexpression, likely through inducing retinal microglial activation and phagocytosis. Microglial depletion via PLX3397 (CSF-1R inhibitor) or inhibition using minocycline (anti-inflammatory tetracycline) significantly mitigated retinal degeneration in RBP4 transgenic (RBP4-Tg) mice. Furthermore, minocycline abolished the enhanced phagocytosis of zymosan in murine microglial BV2 cells induced by RBP4. The application of TAK242 or use of microglia-specific TLR4 knockout markedly reduced retinal neuroinflammation and degeneration in RBP4-Tg mice. Overall, these results suggest that elevated serum and vitreous RBP4 levels may be a risk factor for DR by exacerbating retinal neuronal and vascular injuries. Article Highlights Retinol-binding protein 4 (RBP4) levels are elevated in the vitreous humor of patients with diabetic retinopathy (DR) and in RBP4 transgenic mice. Elevated vitreous RBP4 exacerbates both vascular and neuronal deficits associated with DR in streptozotocin-induced diabetic mice. Hyperglycemia augments the RBP4-induced inflammatory response in retinal microvascular endothelial cells to exacerbate DR-related vascular pathologies. RBP4 triggers retinal microglial activation and phagocytosis via TLR4/nuclear factor-κB/mitogen-activated protein kinase pathway, and microglial depletion or inhibition alleviates RBP4-induced retinal neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Inflammation Biology, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Pharmacology, School of Basic Medical Sciences, Tianjin Medical U…
- Laboratory of Molecular Ophthalmology and Tianjin Key Laboratory of Ocular Trauma, Ministry of Education International Joint Laboratory of Ocular Diseases, Department of Ophthalmology, Tianjin Medical University General…
ORCID-Profile: Mei Du
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shi, Y., Mao, C., Zhang, D., Zhu, Y., Lei, Y., Dong, X., Liao, M., & Du, M. (2026). RBP4 Aggravates Diabetic Retinopathy by Inducing Microglial Activation and Endothelial Inflammation. Diabetes, 75(8), 1460-1476. https://doi.org/10.2337/db25-0816
Vancouver
Shi Y, Mao C, Zhang D, Zhu Y, Lei Y, Dong X, et al. RBP4 Aggravates Diabetic Retinopathy by Inducing Microglial Activation and Endothelial Inflammation. Diabetes. 2026;75(8):1460-1476. doi:10.2337/db25-0816
BibTeX
@article{Shi2026,
author = {Shi, Ying and Mao, Congjuan and Zhang, Di and Zhu, Yanfang and Lei, Yi and Dong, Xue and Liao, Mengyu and Du, Mei},
title = {RBP4 Aggravates Diabetic Retinopathy by Inducing Microglial Activation and Endothelial Inflammation},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {8},
pages = {1460--1476},
doi = {10.2337/db25-0816}
}
EUVIMED